IL93061A - Acids 7 - Fluoro - 8 -) Homo (Piprazine - 1 - Eyal - 4 - Oxo - 1,4 - Dihydrobenzo] B [] 8,1 [Naphthyridine - 3 - Carboxylates, preparation and pharmaceutical preparations and - Google Patents
Acids 7 - Fluoro - 8 -) Homo (Piprazine - 1 - Eyal - 4 - Oxo - 1,4 - Dihydrobenzo] B [] 8,1 [Naphthyridine - 3 - Carboxylates, preparation and pharmaceutical preparations andInfo
- Publication number
- IL93061A IL93061A IL9306190A IL9306190A IL93061A IL 93061 A IL93061 A IL 93061A IL 9306190 A IL9306190 A IL 9306190A IL 9306190 A IL9306190 A IL 9306190A IL 93061 A IL93061 A IL 93061A
- Authority
- IL
- Israel
- Prior art keywords
- naphthyridine
- benzo
- oxo
- dihydro
- methyl
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 96
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000003905 agrochemical Substances 0.000 title claims description 4
- -1 or R3 is H Chemical group 0.000 claims abstract description 81
- 239000001257 hydrogen Substances 0.000 claims abstract description 47
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 47
- 150000003839 salts Chemical class 0.000 claims abstract description 34
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 30
- BJVCSICIEDHBNI-UHFFFAOYSA-N benzo[b][1,8]naphthyridine Chemical class N1=CC=CC2=CC3=CC=CC=C3N=C21 BJVCSICIEDHBNI-UHFFFAOYSA-N 0.000 claims abstract description 23
- 150000002431 hydrogen Chemical class 0.000 claims abstract description 20
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 15
- 229910052731 fluorine Chemical group 0.000 claims abstract description 14
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 11
- 239000011737 fluorine Chemical group 0.000 claims abstract description 10
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims abstract description 8
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 6
- 125000003709 fluoroalkyl group Chemical group 0.000 claims abstract description 6
- CGXLVFZJJOXEDF-UHFFFAOYSA-N 1,8-naphthyridine-3-carboxylic acid Chemical compound N1=CC=CC2=CC(C(=O)O)=CN=C21 CGXLVFZJJOXEDF-UHFFFAOYSA-N 0.000 claims description 40
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 19
- 239000002253 acid Substances 0.000 claims description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims description 16
- 150000002148 esters Chemical class 0.000 claims description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 10
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 7
- 125000006239 protecting group Chemical group 0.000 claims description 7
- 125000001153 fluoro group Chemical group F* 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 6
- 239000002184 metal Substances 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 5
- 125000003282 alkyl amino group Chemical group 0.000 claims description 5
- 239000003085 diluting agent Substances 0.000 claims description 5
- IVNKIXVYFMQYNX-UHFFFAOYSA-N 8-(4-methylpiperazin-1-yl)benzo[b][1,8]naphthyridine Chemical class C1CN(C)CCN1C1=CC=C(C=C2C(N=CC=C2)=N2)C2=C1 IVNKIXVYFMQYNX-UHFFFAOYSA-N 0.000 claims description 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 4
- 125000005605 benzo group Chemical group 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 239000000645 desinfectant Substances 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 150000005054 naphthyridines Chemical class 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- DRTQHJPVMGBUCF-UCVXFZOQSA-N 1-[(2s,3s,4s,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione Chemical class O[C@H]1[C@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UCVXFZOQSA-N 0.000 claims 1
- WLEHCPYCXPALMW-UHFFFAOYSA-N 7-fluoro-1-methyl-8-(3-methylpiperazin-1-yl)-4-oxobenzo[b][1,8]naphthyridine-3-carboxylic acid Chemical compound C1CNC(C)CN1C(C(=CC1=C2)F)=CC1=NC1=C2C(=O)C(C(O)=O)=CN1C WLEHCPYCXPALMW-UHFFFAOYSA-N 0.000 claims 1
- KIOCSOOACPTJNL-UHFFFAOYSA-N 8-(3,4-dimethylpiperazin-1-yl)-1-ethyl-7-fluoro-4-oxobenzo[b][1,8]naphthyridine-3-carboxylic acid Chemical compound C1=C2N=C3N(CC)C=C(C(O)=O)C(=O)C3=CC2=CC(F)=C1N1CCN(C)C(C)C1 KIOCSOOACPTJNL-UHFFFAOYSA-N 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 206
- 239000007787 solid Substances 0.000 description 111
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 111
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 107
- 238000002844 melting Methods 0.000 description 93
- 230000008018 melting Effects 0.000 description 93
- 239000000243 solution Substances 0.000 description 66
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 60
- 239000000725 suspension Substances 0.000 description 56
- 238000003756 stirring Methods 0.000 description 55
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 48
- 239000000047 product Substances 0.000 description 48
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 45
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 39
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 32
- 239000011541 reaction mixture Substances 0.000 description 32
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 30
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 28
- 238000000746 purification Methods 0.000 description 28
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 27
- 238000001816 cooling Methods 0.000 description 25
- 239000000284 extract Substances 0.000 description 25
- 239000002244 precipitate Substances 0.000 description 24
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 24
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 23
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 23
- 238000006243 chemical reaction Methods 0.000 description 23
- 229960001701 chloroform Drugs 0.000 description 23
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 22
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 18
- 239000002904 solvent Substances 0.000 description 18
- 238000001914 filtration Methods 0.000 description 17
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 16
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 16
- 235000019341 magnesium sulphate Nutrition 0.000 description 16
- 239000000706 filtrate Substances 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 14
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 10
- HGINADPHJQTSKN-UHFFFAOYSA-M 3-ethoxy-3-oxopropanoate Chemical compound CCOC(=O)CC([O-])=O HGINADPHJQTSKN-UHFFFAOYSA-M 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 9
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 9
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 8
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 7
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 6
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- KVPNZYACFMNSQN-UHFFFAOYSA-N ethyl 2-(2,7-dichloro-6-fluoroquinoline-3-carbonyl)-3-(dimethylamino)prop-2-enoate Chemical compound FC1=C(Cl)C=C2N=C(Cl)C(C(=O)C(=CN(C)C)C(=O)OCC)=CC2=C1 KVPNZYACFMNSQN-UHFFFAOYSA-N 0.000 description 6
- 229910052749 magnesium Inorganic materials 0.000 description 6
- 239000011777 magnesium Substances 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- JOMNTHCQHJPVAZ-UHFFFAOYSA-N 2-methylpiperazine Chemical compound CC1CNCCN1 JOMNTHCQHJPVAZ-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 239000013522 chelant Substances 0.000 description 5
- ALWUTFXRAKXRNG-UHFFFAOYSA-N 2-chloro-6,7-difluoroquinoline-3-carboxylic acid Chemical compound FC1=C(F)C=C2N=C(Cl)C(C(=O)O)=CC2=C1 ALWUTFXRAKXRNG-UHFFFAOYSA-N 0.000 description 4
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 239000001117 sulphuric acid Substances 0.000 description 4
- 235000011149 sulphuric acid Nutrition 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- WGCYRFWNGRMRJA-UHFFFAOYSA-N 1-ethylpiperazine Chemical compound CCN1CCNCC1 WGCYRFWNGRMRJA-UHFFFAOYSA-N 0.000 description 3
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 3
- GKFRHRIMMMPBGE-UHFFFAOYSA-N 2,7-dichloro-6-fluoroquinoline-3-carboxylic acid Chemical compound FC1=C(Cl)C=C2N=C(Cl)C(C(=O)O)=CC2=C1 GKFRHRIMMMPBGE-UHFFFAOYSA-N 0.000 description 3
- UFYJJHKXRUPOPX-UHFFFAOYSA-N 2-chloro-6,7,8-trifluoroquinoline-3-carboxylic acid Chemical compound FC1=C(F)C(F)=C2N=C(Cl)C(C(=O)O)=CC2=C1 UFYJJHKXRUPOPX-UHFFFAOYSA-N 0.000 description 3
- QXXDDRMZGJKNLO-UHFFFAOYSA-N 2-ethoxy-6,7,8-trifluoro-1h-quinolin-4-one Chemical compound C1=C(F)C(F)=C(F)C2=NC(OCC)=CC(O)=C21 QXXDDRMZGJKNLO-UHFFFAOYSA-N 0.000 description 3
- QZZLIESIUUAOBI-UHFFFAOYSA-N 4-chloro-2-ethoxy-6,7,8-trifluoroquinoline Chemical compound C1=C(F)C(F)=C(F)C2=NC(OCC)=CC(Cl)=C21 QZZLIESIUUAOBI-UHFFFAOYSA-N 0.000 description 3
- CYIWHTLIELYOLA-UHFFFAOYSA-N 4-chloro-6,7,8-trifluoro-1h-quinolin-2-one Chemical compound ClC1=CC(=O)NC2=C1C=C(F)C(F)=C2F CYIWHTLIELYOLA-UHFFFAOYSA-N 0.000 description 3
- VZNNMTNTTIQWLL-UHFFFAOYSA-N 6,7,8-trifluoro-1h-quinolin-2-one Chemical compound C1=CC(=O)NC2=C1C=C(F)C(F)=C2F VZNNMTNTTIQWLL-UHFFFAOYSA-N 0.000 description 3
- QTDMTWLSJYBOJH-UHFFFAOYSA-N 6,7,8-trifluoro-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(=O)NC2=C1C=C(F)C(F)=C2F QTDMTWLSJYBOJH-UHFFFAOYSA-N 0.000 description 3
- HVPNETSYDVJGQX-UHFFFAOYSA-N 6,7-difluoro-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(=O)NC2=C1C=C(F)C(F)=C2 HVPNETSYDVJGQX-UHFFFAOYSA-N 0.000 description 3
- GMEQKMFQAAMTCJ-UHFFFAOYSA-N 7-chloro-6-fluoro-3,4-dihydro-1h-quinolin-2-one Chemical compound C1CC(=O)NC2=C1C=C(F)C(Cl)=C2 GMEQKMFQAAMTCJ-UHFFFAOYSA-N 0.000 description 3
- FUODODDYGZFWKA-UHFFFAOYSA-N 8-chloro-7-fluoro-1-methyl-4-oxobenzo[b][1,8]naphthyridine-3-carboxylic acid Chemical compound FC1=C(Cl)C=C2N=C3N(C)C=C(C(O)=O)C(=O)C3=CC2=C1 FUODODDYGZFWKA-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- KGXIRGSEGOXSPY-UHFFFAOYSA-N ethyl 2-(2-chloro-6,7,8-trifluoroquinoline-3-carbonyl)-3-(dimethylamino)prop-2-enoate Chemical compound FC1=C(F)C(F)=C2N=C(Cl)C(C(=O)C(=CN(C)C)C(=O)OCC)=CC2=C1 KGXIRGSEGOXSPY-UHFFFAOYSA-N 0.000 description 3
- NPVMPUAUNRMWTB-UHFFFAOYSA-N ethyl 2-(2-chloro-6,7-difluoroquinoline-3-carbonyl)-3-(cyclopropylamino)prop-2-enoate Chemical compound C=1C2=CC(F)=C(F)C=C2N=C(Cl)C=1C(=O)C(C(=O)OCC)=CNC1CC1 NPVMPUAUNRMWTB-UHFFFAOYSA-N 0.000 description 3
- CFLWTTHFSBUPGC-UHFFFAOYSA-N ethyl 3-(2,7-dichloro-6-fluoroquinolin-3-yl)-3-oxopropanoate Chemical compound FC1=C(Cl)C=C2N=C(Cl)C(C(=O)CC(=O)OCC)=CC2=C1 CFLWTTHFSBUPGC-UHFFFAOYSA-N 0.000 description 3
- 239000012065 filter cake Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 150000004885 piperazines Chemical class 0.000 description 3
- 239000012286 potassium permanganate Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 3
- 239000008247 solid mixture Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 2
- FQUYSHZXSKYCSY-UHFFFAOYSA-N 1,4-diazepane Chemical compound C1CNCCNC1 FQUYSHZXSKYCSY-UHFFFAOYSA-N 0.000 description 2
- LMAUFDNHHWZXCS-UHFFFAOYSA-N 2,7-dichloro-6-fluoro-1,4-dihydroquinoline-3-carbaldehyde Chemical compound C1C(C=O)=C(Cl)NC2=C1C=C(F)C(Cl)=C2 LMAUFDNHHWZXCS-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- BVOUDZPODLRKHZ-UHFFFAOYSA-N 2-chloro-6,7-difluoro-1,4-dihydroquinoline-3-carbaldehyde Chemical compound C1C(C=O)=C(Cl)NC2=C1C=C(F)C(F)=C2 BVOUDZPODLRKHZ-UHFFFAOYSA-N 0.000 description 2
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 description 2
- INUNLMUAPJVRME-UHFFFAOYSA-N 3-chloropropanoyl chloride Chemical compound ClCCC(Cl)=O INUNLMUAPJVRME-UHFFFAOYSA-N 0.000 description 2
- NVSMJVYBCAZMLJ-UHFFFAOYSA-N 7-fluoro-1-(methylamino)-4-oxo-8-piperazin-1-ylbenzo[b][1,8]naphthyridine-3-carboxylic acid Chemical compound C1=C2N=C3N(NC)C=C(C(O)=O)C(=O)C3=CC2=CC(F)=C1N1CCNCC1 NVSMJVYBCAZMLJ-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 229950005499 carbon tetrachloride Drugs 0.000 description 2
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- COMYBBUQYYTAQX-UHFFFAOYSA-N ethyl 2-(2-chloro-6,7-difluoroquinoline-3-carbonyl)-3-(dimethylamino)prop-2-enoate Chemical compound FC1=C(F)C=C2N=C(Cl)C(C(=O)C(=CN(C)C)C(=O)OCC)=CC2=C1 COMYBBUQYYTAQX-UHFFFAOYSA-N 0.000 description 2
- ALCWIRSIQDTRHT-UHFFFAOYSA-N ethyl 3-(2-chloro-6,7-difluoroquinolin-3-yl)-3-oxopropanoate Chemical compound FC1=C(F)C=C2N=C(Cl)C(C(=O)CC(=O)OCC)=CC2=C1 ALCWIRSIQDTRHT-UHFFFAOYSA-N 0.000 description 2
- HYMXUYQKXCHWDC-UHFFFAOYSA-N ethyl 3-ethoxy-3-iminopropanoate;hydrochloride Chemical compound Cl.CCOC(=N)CC(=O)OCC HYMXUYQKXCHWDC-UHFFFAOYSA-N 0.000 description 2
- 125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 description 2
- 150000004677 hydrates Chemical class 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000003701 inert diluent Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- RSFOTOSOKJMMCB-UHFFFAOYSA-N n-amino-n-methylformamide Chemical compound CN(N)C=O RSFOTOSOKJMMCB-UHFFFAOYSA-N 0.000 description 2
- 235000011837 pasties Nutrition 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 150000003248 quinolines Chemical class 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- MAUMSNABMVEOGP-UHFFFAOYSA-N (methyl-$l^{2}-azanyl)methane Chemical compound C[N]C MAUMSNABMVEOGP-UHFFFAOYSA-N 0.000 description 1
- PDQRQJVPEFGVRK-UHFFFAOYSA-N 2,1,3-benzothiadiazole Chemical compound C1=CC=CC2=NSN=C21 PDQRQJVPEFGVRK-UHFFFAOYSA-N 0.000 description 1
- UTQNKKSJPHTPBS-UHFFFAOYSA-N 2,2,2-trichloroethanone Chemical group ClC(Cl)(Cl)[C]=O UTQNKKSJPHTPBS-UHFFFAOYSA-N 0.000 description 1
- PIPWSBOFSUJCCO-UHFFFAOYSA-N 2,2-dimethylpiperazine Chemical compound CC1(C)CNCCN1 PIPWSBOFSUJCCO-UHFFFAOYSA-N 0.000 description 1
- IFNWESYYDINUHV-UHFFFAOYSA-N 2,6-dimethylpiperazine Chemical compound CC1CNCC(C)N1 IFNWESYYDINUHV-UHFFFAOYSA-N 0.000 description 1
- DINZOYJTUZYKNI-UHFFFAOYSA-N 2-(2-chloro-6,7-difluoroquinoline-3-carbonyl)-3-(dimethylamino)prop-2-enoic acid Chemical compound FC1=C(F)C=C2N=C(Cl)C(C(=O)C(C(O)=O)=CN(C)C)=CC2=C1 DINZOYJTUZYKNI-UHFFFAOYSA-N 0.000 description 1
- PSMXGKUBAXWYNH-UHFFFAOYSA-N 2-(ethylamino)prop-2-enoic acid Chemical compound CCNC(=C)C(O)=O PSMXGKUBAXWYNH-UHFFFAOYSA-N 0.000 description 1
- FSAIASGOPGKUTF-UHFFFAOYSA-N 2-chloro-6,7,8-trifluoro-1,4-dihydroquinoline-3-carbaldehyde Chemical compound C1C(C=O)=C(Cl)NC2=C1C=C(F)C(F)=C2F FSAIASGOPGKUTF-UHFFFAOYSA-N 0.000 description 1
- YRRZGBOZBIVMJT-UHFFFAOYSA-N 2-fluoroethanamine;hydron;chloride Chemical compound Cl.NCCF YRRZGBOZBIVMJT-UHFFFAOYSA-N 0.000 description 1
- AXNUZKSSQHTNPZ-UHFFFAOYSA-N 3,4-difluoroaniline Chemical compound NC1=CC=C(F)C(F)=C1 AXNUZKSSQHTNPZ-UHFFFAOYSA-N 0.000 description 1
- KOWPUNQBGWIERF-UHFFFAOYSA-N 3-bromo-4-fluoroaniline Chemical compound NC1=CC=C(F)C(Br)=C1 KOWPUNQBGWIERF-UHFFFAOYSA-N 0.000 description 1
- YSEMCVGMNUUNRK-UHFFFAOYSA-N 3-chloro-4-fluoroaniline Chemical compound NC1=CC=C(F)C(Cl)=C1 YSEMCVGMNUUNRK-UHFFFAOYSA-N 0.000 description 1
- PGGSKHQAZWUEGS-UHFFFAOYSA-N 6,7,8-trifluoro-1-methoxy-4-oxobenzo[b][1,8]naphthyridine-3-carboxylic acid Chemical compound FC1=C(F)C=C2N=C3N(OC)C=C(C(O)=O)C(=O)C3=CC2=C1F PGGSKHQAZWUEGS-UHFFFAOYSA-N 0.000 description 1
- MIPXXHOULKLDAX-UHFFFAOYSA-N 7,8-difluoro-1-methoxy-4-oxobenzo[b][1,8]naphthyridine-3-carboxylic acid Chemical compound FC1=C(F)C=C2N=C3N(OC)C=C(C(O)=O)C(=O)C3=CC2=C1 MIPXXHOULKLDAX-UHFFFAOYSA-N 0.000 description 1
- PQKPNAYTMNETQE-UHFFFAOYSA-N 7,9-difluoro-1-methoxy-4-oxo-8-piperazin-1-ylbenzo[b][1,8]naphthyridine-3-carboxylic acid Chemical compound FC1=C2N=C3N(OC)C=C(C(O)=O)C(=O)C3=CC2=CC(F)=C1N1CCNCC1 PQKPNAYTMNETQE-UHFFFAOYSA-N 0.000 description 1
- JLDXOKZUZMTFOO-UHFFFAOYSA-N 7-bromo-2-chloro-6-fluoroquinoline-3-carboxylic acid Chemical compound FC1=C(Br)C=C2N=C(Cl)C(C(=O)O)=CC2=C1 JLDXOKZUZMTFOO-UHFFFAOYSA-N 0.000 description 1
- SHRNCBCAUAPVAY-UHFFFAOYSA-N 7-fluoro-1-(methylamino)-8-(3-methylpiperazin-1-yl)-4-oxobenzo[b][1,8]naphthyridine-3-carboxylic acid Chemical compound C1=C2N=C3N(NC)C=C(C(O)=O)C(=O)C3=CC2=CC(F)=C1N1CCNC(C)C1 SHRNCBCAUAPVAY-UHFFFAOYSA-N 0.000 description 1
- DZWXGCBQSJQUCC-UHFFFAOYSA-N 7-fluoro-8-[4-(2-hydroxyethyl)piperazin-1-yl]-1-methyl-4-oxobenzo[b][1,8]naphthyridine-3-carboxylic acid Chemical compound C1=C2N=C3N(C)C=C(C(O)=O)C(=O)C3=CC2=CC(F)=C1N1CCN(CCO)CC1 DZWXGCBQSJQUCC-UHFFFAOYSA-N 0.000 description 1
- WUGBWAJUKFELCG-UHFFFAOYSA-N 8-(1,4-diazepan-1-yl)-7,9-difluoro-1-methyl-4-oxobenzo[b][1,8]naphthyridine-3-carboxylic acid Chemical compound FC1=C2N=C3N(C)C=C(C(O)=O)C(=O)C3=CC2=CC(F)=C1N1CCCNCC1 WUGBWAJUKFELCG-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001245789 Goodea atripinnis Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 241000009298 Trigla lyra Species 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000020176 deacylation Effects 0.000 description 1
- 238000005947 deacylation reaction Methods 0.000 description 1
- 229960002887 deanol Drugs 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 239000012972 dimethylethanolamine Substances 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- MGHPNCMVUAKAIE-UHFFFAOYSA-N diphenylmethanamine Chemical compound C=1C=CC=CC=1C(N)C1=CC=CC=C1 MGHPNCMVUAKAIE-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
- LFPBONFIEKFNKE-UHFFFAOYSA-N ethyl 1-cyclopropyl-7,9-difluoro-8-(3-methylpiperazin-1-yl)-4-oxobenzo[b][1,8]naphthyridine-3-carboxylate Chemical compound C12=NC3=C(F)C(N4CC(C)NCC4)=C(F)C=C3C=C2C(=O)C(C(=O)OCC)=CN1C1CC1 LFPBONFIEKFNKE-UHFFFAOYSA-N 0.000 description 1
- YOXRSOYYLBDSIX-UHFFFAOYSA-N ethyl 1-ethyl-7,9-difluoro-4-oxo-8-piperazin-1-ylbenzo[b][1,8]naphthyridine-3-carboxylate Chemical compound FC=1C=C2C=C3C(=O)C(C(=O)OCC)=CN(CC)C3=NC2=C(F)C=1N1CCNCC1 YOXRSOYYLBDSIX-UHFFFAOYSA-N 0.000 description 1
- KCWODRPTUOYLHF-UHFFFAOYSA-N ethyl 3-(2-chloro-6,7,8-trifluoroquinolin-3-yl)-3-oxopropanoate Chemical compound FC1=C(F)C(F)=C2N=C(Cl)C(C(=O)CC(=O)OCC)=CC2=C1 KCWODRPTUOYLHF-UHFFFAOYSA-N 0.000 description 1
- OMLGUQIAZMZLRF-UHFFFAOYSA-N ethyl 7,9-difluoro-1-methyl-4-oxo-8-piperazin-1-ylbenzo[b][1,8]naphthyridine-3-carboxylate Chemical compound FC=1C=C2C=C3C(=O)C(C(=O)OCC)=CN(C)C3=NC2=C(F)C=1N1CCNCC1 OMLGUQIAZMZLRF-UHFFFAOYSA-N 0.000 description 1
- LIDFHYKEZGTJBF-UHFFFAOYSA-N ethyl 8-(1,4-diazepan-1-yl)-1-ethyl-7,9-difluoro-4-oxobenzo[b][1,8]naphthyridine-3-carboxylate Chemical compound FC=1C=C2C=C3C(=O)C(C(=O)OCC)=CN(CC)C3=NC2=C(F)C=1N1CCCNCC1 LIDFHYKEZGTJBF-UHFFFAOYSA-N 0.000 description 1
- CHEUKPVYDZATTH-UHFFFAOYSA-N ethyl 8-(1,4-diazepan-1-yl)-7,9-difluoro-1-methyl-4-oxobenzo[b][1,8]naphthyridine-3-carboxylate Chemical compound FC=1C=C2C=C3C(=O)C(C(=O)OCC)=CN(C)C3=NC2=C(F)C=1N1CCCNCC1 CHEUKPVYDZATTH-UHFFFAOYSA-N 0.000 description 1
- WPNQCYURFXAURU-UHFFFAOYSA-N ethyl 8-chloro-1-cyclopropyl-7-fluoro-4-oxobenzo[b][1,8]naphthyridine-3-carboxylate Chemical compound C12=NC3=CC(Cl)=C(F)C=C3C=C2C(=O)C(C(=O)OCC)=CN1C1CC1 WPNQCYURFXAURU-UHFFFAOYSA-N 0.000 description 1
- VOOXUOVJUATJFK-UHFFFAOYSA-N ethyl 8-chloro-7-fluoro-1-(2-fluoroethyl)-4-oxobenzo[b][1,8]naphthyridine-3-carboxylate Chemical compound ClC1=C(F)C=C2C=C(C(C(C(=O)OCC)=CN3CCF)=O)C3=NC2=C1 VOOXUOVJUATJFK-UHFFFAOYSA-N 0.000 description 1
- BLSKSSFBGARNAA-UHFFFAOYSA-N ethyl 8-chloro-7-fluoro-1-methyl-4-oxobenzo[b][1,8]naphthyridine-3-carboxylate Chemical compound ClC1=C(F)C=C2C=C(C(C(C(=O)OCC)=CN3C)=O)C3=NC2=C1 BLSKSSFBGARNAA-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000004770 highest occupied molecular orbital Methods 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- RGZRSLKIOCHTSI-UHFFFAOYSA-N hydron;n-methylhydroxylamine;chloride Chemical compound Cl.CNO RGZRSLKIOCHTSI-UHFFFAOYSA-N 0.000 description 1
- XNXVOSBNFZWHBV-UHFFFAOYSA-N hydron;o-methylhydroxylamine;chloride Chemical compound Cl.CON XNXVOSBNFZWHBV-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- KERBAAIBDHEFDD-UHFFFAOYSA-N n-ethylformamide Chemical compound CCNC=O KERBAAIBDHEFDD-UHFFFAOYSA-N 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002895 organic esters Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- CFHIDWOYWUOIHU-UHFFFAOYSA-N oxomethyl Chemical compound O=[CH] CFHIDWOYWUOIHU-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical class CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR898900430A FR2641783B1 (fr) | 1989-01-16 | 1989-01-16 | Nouveaux derives de benzonaphtyridine-1,8, leur preparation et les compositions qui les contiennent |
| FR8910218A FR2650279B1 (fr) | 1989-07-28 | 1989-07-28 | Nouveaux derives de benzonaphtyridine-1,8 leur preparation et les compositions qui les contiennent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL93061A0 IL93061A0 (en) | 1990-11-05 |
| IL93061A true IL93061A (en) | 1994-05-30 |
Family
ID=26227107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL9306190A IL93061A (en) | 1989-01-16 | 1990-01-15 | Acids 7 - Fluoro - 8 -) Homo (Piprazine - 1 - Eyal - 4 - Oxo - 1,4 - Dihydrobenzo] B [] 8,1 [Naphthyridine - 3 - Carboxylates, preparation and pharmaceutical preparations and |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5004745A (de) |
| EP (1) | EP0379412B1 (de) |
| JP (1) | JPH02247176A (de) |
| KR (1) | KR900011770A (de) |
| AT (1) | ATE97899T1 (de) |
| AU (1) | AU623474B2 (de) |
| CA (1) | CA2007759A1 (de) |
| DE (1) | DE69004815T2 (de) |
| DK (1) | DK0379412T3 (de) |
| ES (1) | ES2060970T3 (de) |
| HU (1) | HU205115B (de) |
| IE (1) | IE63064B1 (de) |
| IL (1) | IL93061A (de) |
| NZ (1) | NZ232091A (de) |
| PT (1) | PT92876B (de) |
| RU (3) | RU1836370C (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ232092A (en) * | 1989-01-16 | 1992-05-26 | Bellon Labor Sa Roger | 8-halo-7-fluoro-4-oxo-1,4-dihydro-benzo(b)(1,8) naphthyridine-3-carboxylic acid esters and preparation thereof |
| AU623475B2 (en) * | 1989-01-16 | 1992-05-14 | Laboratoire Roger Bellon | New benzo(1,8)naphthyridine derivatives, their preparation and compositions containing them |
| RO108347B1 (ro) * | 1989-10-30 | 1994-04-28 | Bellon Labor Sa Roger | DERIVATI DE BENZO-(b)-NAFTIRIDIN-1,8 SI PROCEDEU DE PREPARARE A ACESTORA |
| ES2150904T3 (es) * | 1990-05-02 | 2000-12-16 | Abbott Lab | Compuestos de tipo quinolizinona. |
| US5556861A (en) * | 1991-10-01 | 1996-09-17 | Laboratoire Roger Bellon | 1,8 benzonaphthyridine derivatives and antimicrobial compositions |
| FR2682378B1 (fr) * | 1991-10-10 | 1995-04-07 | Bellon Laboratoires | Nouveaux derives de l'acide fluoroquinoleine carboxylique-3 et leur preparation. |
| FR2682384B1 (fr) * | 1991-10-10 | 1995-04-07 | Bellon Laboratoires | Procede de preparation de benzo (b) naphtyridines. |
| FR2703681B1 (fr) * | 1993-04-08 | 1995-05-12 | Bellon Labor Sa Roger | Procede de preparation de fluoro-6-halogeno-2 quinoleine |
| US6080745A (en) * | 1993-09-15 | 2000-06-27 | Merck Sharp & Dohme Limited | Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands |
| NZ310542A (en) * | 1995-08-29 | 1999-09-29 | Pfizer | Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin selected from its polymorph, its pseodomorphs and the monohydrate, preparation and pharmaceutical compositions thereof |
| EP0850060A1 (de) * | 1995-08-29 | 1998-07-01 | Pfizer Inc. | Zwitterionische formen des trovalfloxazins |
| FR2787452B1 (fr) * | 1998-12-21 | 2004-10-22 | Aventis Pharma Sa | Nouveaux derives de la benzonaphtyridine-1,8, leur preparation et les compositions pharmaceutiques qui les contiennent |
| EP1140932B1 (de) | 1998-12-21 | 2004-03-17 | Aventis Pharma S.A. | Benzonaphtyridin-1,8 derivate |
| FR2816618B1 (fr) | 2000-11-15 | 2002-12-27 | Aventis Pharma Sa | Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent |
| WO2013157018A1 (en) | 2012-04-18 | 2013-10-24 | Indian Institute Of Technology Madras | A process for the preparation of the core structure in quinolone and napthyridone class of antibiotics |
| WO2018092928A1 (ko) * | 2016-11-16 | 2018-05-24 | 주식회사 진웅산업 | 벤조나프티리딘 화합물 및 이를 포함하는 유기발광소자 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4229456A (en) * | 1977-07-18 | 1980-10-21 | Merck & Co., Inc. | Substituted naphthyridinones and processes for their preparations |
| US4133885A (en) * | 1977-07-18 | 1979-01-09 | Merck & Co., Inc. | Substituted naphthyridinones |
| AR223983A1 (es) * | 1978-08-25 | 1981-10-15 | Dainippon Pharmaceutical Co | Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico |
| JPS59137482A (ja) * | 1983-01-26 | 1984-08-07 | Otsuka Pharmaceut Co Ltd | ピロロ〔３，２，１，−ｉｊ〕キノリン−５−カルボン酸誘導体 |
| DE3333719A1 (de) * | 1983-09-17 | 1985-04-04 | Bayer Ag | Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren |
| AU585981B2 (en) * | 1985-05-24 | 1989-06-29 | Tokyo Tanabe Company Limited | Benzo (IJ) quinolizine-2-carboxylic acid derivatives, the salts and their hydrates, pharmaceutical compositions thereof, and processes for preparing the same |
| NZ232092A (en) * | 1989-01-16 | 1992-05-26 | Bellon Labor Sa Roger | 8-halo-7-fluoro-4-oxo-1,4-dihydro-benzo(b)(1,8) naphthyridine-3-carboxylic acid esters and preparation thereof |
| AU623475B2 (en) * | 1989-01-16 | 1992-05-14 | Laboratoire Roger Bellon | New benzo(1,8)naphthyridine derivatives, their preparation and compositions containing them |
-
1990
- 1990-01-12 NZ NZ232091A patent/NZ232091A/en unknown
- 1990-01-12 AU AU47947/90A patent/AU623474B2/en not_active Ceased
- 1990-01-15 DE DE90400104T patent/DE69004815T2/de not_active Expired - Fee Related
- 1990-01-15 HU HU90141A patent/HU205115B/hu not_active IP Right Cessation
- 1990-01-15 CA CA002007759A patent/CA2007759A1/fr not_active Abandoned
- 1990-01-15 EP EP90400104A patent/EP0379412B1/de not_active Expired - Lifetime
- 1990-01-15 ES ES90400104T patent/ES2060970T3/es not_active Expired - Lifetime
- 1990-01-15 RU SU904742889A patent/RU1836370C/ru active
- 1990-01-15 IL IL9306190A patent/IL93061A/en not_active IP Right Cessation
- 1990-01-15 KR KR1019900000524A patent/KR900011770A/ko not_active Withdrawn
- 1990-01-15 DK DK90400104.7T patent/DK0379412T3/da active
- 1990-01-15 AT AT90400104T patent/ATE97899T1/de not_active IP Right Cessation
- 1990-01-15 IE IE15890A patent/IE63064B1/en not_active IP Right Cessation
- 1990-01-16 PT PT92876A patent/PT92876B/pt not_active IP Right Cessation
- 1990-01-16 US US07/465,483 patent/US5004745A/en not_active Expired - Fee Related
- 1990-01-16 JP JP2006983A patent/JPH02247176A/ja active Pending
-
1991
- 1991-01-20 RU SU914894280A patent/RU1811530C/ru active
-
1992
- 1992-07-07 RU SU925011907A patent/RU2042677C1/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2007759A1 (fr) | 1990-07-16 |
| EP0379412B1 (de) | 1993-12-01 |
| AU623474B2 (en) | 1992-05-14 |
| IE900158L (en) | 1990-07-16 |
| DK0379412T3 (da) | 1994-02-07 |
| JPH02247176A (ja) | 1990-10-02 |
| US5004745A (en) | 1991-04-02 |
| ATE97899T1 (de) | 1993-12-15 |
| KR900011770A (ko) | 1990-08-02 |
| PT92876A (pt) | 1990-07-31 |
| NZ232091A (en) | 1990-12-21 |
| AU4794790A (en) | 1990-07-19 |
| IE63064B1 (en) | 1995-03-22 |
| RU2042677C1 (ru) | 1995-08-27 |
| DE69004815D1 (de) | 1994-01-13 |
| ES2060970T3 (es) | 1994-12-01 |
| RU1836370C (ru) | 1993-08-23 |
| EP0379412A1 (de) | 1990-07-25 |
| HU900141D0 (en) | 1990-03-28 |
| IL93061A0 (en) | 1990-11-05 |
| PT92876B (pt) | 1995-11-30 |
| RU1811530C (ru) | 1993-04-23 |
| DE69004815T2 (de) | 1994-04-07 |
| HU205115B (en) | 1992-03-30 |
| HUT53366A (en) | 1990-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5004745A (en) | Benzo[1,8]naphthyridine derivatives, their preparation and the compositions which contain them | |
| FI66379C (fi) | Analogifoerfarande foer framstaellning av terapeutiskt anvaendbara 6-halogen-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1-substituerade 1,8-naftyridin-3-karboxylsyror och salter daerav | |
| DK160276B (da) | 7-(3-aminosubstitueret-1-pyrrolidinyl)-1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carboxylsyrederivater, salte eller hydrater deraf | |
| GB2190376A (en) | Quinolinecarboxylic acid derivatives | |
| US5053509A (en) | Benzo[1,8]naphthyridine derivatives, their preparation and compositions containing them | |
| CA1153374A (en) | Piperazinylbenzoheterocyclic compounds | |
| NZ244518A (en) | Benzo[b][1,8] naphthyridine derivatives and pharmaceutical compositions | |
| US4970213A (en) | Benzo(1,8)naphthyridine derivatives as intermediates | |
| US4990515A (en) | Benzo[1,8]naphthyridine derivatives as antimicrobials | |
| IE872444L (en) | Pyrido-benzoxadiazine derivatives | |
| GB1598915A (en) | 1,4-dihydro-quinoline-3-carboxylic acid derivatives process for their preparation and composition containing them | |
| EP0286089B1 (de) | Chinolincarbonsäure-Derivate, diese enthaltende Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Medikamenten | |
| KR900009024B1 (ko) | 퀴놀론카르복실산 화합물 및 이의 약학적 용도 | |
| CA2012063A1 (en) | Quinolinecarboxylic acid derivatives and antibacterial agent containing the same | |
| US5556861A (en) | 1,8 benzonaphthyridine derivatives and antimicrobial compositions | |
| HU206501B (en) | Process for producing new 1,8-benzonaphtiridine derivatives and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RH | Patent void |